Cerebroprotein Hydrolysate Injection (EVER Neuro Pharma)

脑蛋白水解物注射液 (EVER Neuro Pharma)

Report date: 2023/02/27 17:44:31

Base Information

Drug NameCerebroprotein Hydrolysate Injection (EVER Neuro Pharma)
Drug Alias Name施普善CerebrolysinFPF-1070
ClassificationBiologics > Protein drugs > Recombinant polypeptideNatural product/Extract > Animal extract
Mechanisms of ActionNeurons stimulants
TargetsNot applicable
Therapy Area/IndicationsIschemic StrokeTaste DisordersOlfaction Disorders +[8] 
Global Approved IndicationsAlzheimer DiseaseDementiaStroke +[5] 
Approved Indications in ChinaDementiaStroke
Original Approved Country/TerritoryGermany
Original Approved Date2000/01/01
Country/TerritoryPolandAustriaGermany +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEbewe Pharma
China Registration ClassN/A

Develop Information

Active CompaniesMilitary Institute of Medicine National Research InstituteEver Neuro Pharma GmbhAssiut University +[4] 
Inactive CompaniesPomeranian Medical University
Active IndicationsIschemic StrokeTaste DisordersOlfaction Disorders +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeB05BA04
Related LinksWikipedia